Table 1. The outcomes of liver transplantations using a SFSG

Year of study	Study	Country	Definition	Number of SFSG group	Number of control group	Incidence of SFSS (%)	Short-term mortality in SFSG	Long-term mortality (OR, 90% CI)
2008	Yi	Korea	<0.8% GRWR	29	-	-	0% in Right 33% in Left	-
2008	Ikegami	Japan	<35% GV/SLV	33	87	0	12.5% (1 yr)	3.25 (1.29-8.18)
2009	Selzner	Canada	<0.8% GRWR	22	249	9	4.5% (30 days)	0.82 (0.27-2.60)
2010	Moon	Korea	<0.8% GRWR	35	392	5.7	-	1.33 (0.60-2.95)
2014	Lee	Korea	<0.8% GRWR	50	267	8	2% (1 yr)	1.61 (0.72-3.63)*
2015	Au	HongKong	<35% GV/SLV	21	212	-	-	1.61 (0.51-5.15)
2015	Liu	China	<0.8% GRWR	65	181	11	7.7% (30 days)	1.23 (0.65-2.34)
2016	Ikegami	Japan	<35% GV/SLV	88	119	11.4	-	0.69 (0.28-1.72)

SFSG, small for size graft; SFSS, small for size syndrome; OR, odds ratio; CI, confidence interval; GRWR, graft-versus-recipient weight ratio; GV, graft volume; SLV, standard liver volume.
3-yr follow up.